A Study of LY2951742 in Participants With Chronic Cluster Headache

Condition:   Chronic Cluster Headache
Interventions:   Drug: LY2951742;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Recruiting – verified September 2017
Source: ClinicalTrials.gov Listing of Cluster Headache trials
The main purpose of this study is to evaluate the efficacy of the study drug known as LY2951742 in participants with chronic cluster headache.